Cisplatin in cancer therapy: molecular mechanisms of action
By Shaloam Dasari, P. Tchounwou. European Journal of Pharmacology, 2014
5,019 citations recorded by the source corpus.
Cisplatin, cisplatinum, or cis-diamminedichloroplatinum (II), is a well-known chemotherapeutic drug. It has been used for treatment of numerous human cancers including bladder, head and neck, lung, ovarian, and testicular cancers. It is effective against various types of cancers, including carcinomas, germ cell tumors, lymphomas, and sarcomas. Its mode of action has been linked to its ability to crosslink with the purine bases on the DNA; interfering with DNA repair mechanisms, causing DNA damage, and subsequently inducing apoptosis in cancer cells. However, because of drug resistance and numerous undesirable side effects such as severe kidney problems, allergic reactions, decrease immunity to infections, gastrointestinal disorders, hemorrhage, and hearing loss especially in younger patients, other platinum-containing anti-cancer drugs such as carboplatin, oxaliplatin and others, have also been used. Furthermore, combination therapies of cisplatin with other drugs have been highly considered to overcome drug-resistance and reduce toxicity. This comprehensive review highlights the physicochemical properties of cisplatin and related platinum-based drugs, and discusses its uses (either alone or in combination with other drugs) for the treatment of various human cancers. A special attention is given to its molecular mechanisms of action, and its undesirable side effects.
Subfields: Molecular Biology, Oncology, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/a937be562ff9f68e73e6cc94d306751ad5df7c33
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Oncology
In Pathology and Forensic Medicine
Citations in the corpus
- Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer (2017, background): “This compound has been found to be effective against various cancer lines, including testicular, ovarian and solid tumours of the head and neck [266–271].”
- Cisplatin: The first metal based anticancer drug. (2019, background): “which makes higher sensitivity to cisplatin [12].”
- Platinum-based drugs for cancer therapy and anti-tumor strategies (2022, background): “After a series of chemical reactions in the cytoplasm, platinum binds to DNA by forming intra- and interstranded crosslinks, changing the DNA structure and causing DNA damage (Figure 1A) [46, 47].”